Cytotoxic T Lymphocytes for Treating Malignancies With BK and/or JC Virus
Phase 2
100
about 12 years
All ages
1 site in TX
Why this study is shown
What this study is about
This trial is testing if donor cytotoxic T lymphocytes can help treat patients with malignancies that have BK and/or JC virus. Cytotoxic T lymphocytes are made from donated blood cells grown in a lab to kill viruses, potentially offering an effective treatment option for these specific cancers.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Laboratory Biomarker Analysis
- 2.Receive Allogeneic BK-specific Cytotoxic T-lymphocytes
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Incidence of adverse events
Secondary: Overall survival
Oncology, Immune, Infectious